IP Library › Granted Patent US 11,633,100
Granted Patent B2
US 11,633,100 · App. 16/391,614 · Granted Apr 25, 2023

Stroke, concussion, and cognitive dysfunction diagnostic method and device

Inventors: Ghassan S. Kassab (La Jolla, CA); Ali Dabiri (San Diego, CA)
Assignee: 3DT Holdings, LLC
A61B3/1241A61B5/0071A61B5/4064A61B5/4088
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,633,100
App. No.
16/391,614
Granted
Apr 25, 2023
Kind
B2
Abstract

A method of detecting injury to the brain such as stroke, concussion and cognitive dysfunction using a contrast agent and light source. The blood ocular barrier is disrupted when said injury occurs, allowing the entry of contrast agent into the aqueous and vitreous humor. An exemplary method comprises injecting a contrast agent into a peripheral location and then testing for leakage of contrast agent into the eye cavity by observing for light reflection, when a beam of light incidents on the contrast agent in the eye.

Claims (12)

1. A method of diagnosing stroke/concussion/cognitive dysfunction in a patient through detection of a contrast agent in an eye of the patient comprising the steps of:

injecting the contrast agent into a peripheral vessel of the patient;

emitting a light into the eye of the patient, the light having a wavelength such that the light is absorbable by the contrast agent, wherein the light passes through an anterior chamber and/or a vitreous chamber of the eye where the light will be at least partially absorbed by the contrast agent present in the anterior chamber and/or the vitreous chamber of the eye, and a remainder of the light that is not absorbed by the contrast agent is reflected from the eye;

detecting the remainder of the light reflected from the eye;

detecting a presence or an absence of the contrast agent in the anterior chamber and/or the vitreous chamber of the eye by determining a difference between the remainder of the light reflected by the eye and the light emitted into the eye, wherein when the remainder of the light reflected by the eye is less than the light emitted into the eye indicates the presence of contrast agent in the anterior chamber and/or the vitreous chamber of the eye;

diagnosing stroke/concussion/cognitive dysfunction based on the presence of the contrast agent in the anterior chamber and/or the vitreous chamber of the eye; and

wherein the contrast agent comprises gadolinium.

2. The method of claim 1 , wherein the contrast agent is injected at a location other than the eye.

3. The method of claim 1 , wherein the steps of emitting a light into the eye and detecting the remainder of the light reflected from the eye are performed using an ultraviolet (UV) emission and a detection device.

4. The method of claim 3 , wherein the wavelength of the light is between 200-300 nm.

5. The method of claim 1 , wherein the steps of emitting light into the eye and detecting the remainder of the light reflected from the eye are performed using a combination light emission and detection device.

6. The method of claim 1 , wherein the step of emitting light into the eye is performed using a light emission device and the step of detecting the remainder of the light reflected from the eye is performed using a light detection device separate from the light emission device.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 14, 2022
From: KASSAB, GHASSAN S.; DABIRI, ALI
To: 3DT HOLDINGS, LLC
Reel/Frame 058999/0398 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2022
From: KASSAB, GHASSAN S.; DABIRI, ALI
To: 3DT HOLDINGS, LLC
Reel/Frame 058824/0893 →
Continuity (3)
Provisional Application 62673192 · May 18, 2018
Provisional Application 62661284 · Apr 23, 2018
Related Publication 20190320896A1 · Oct 24, 2019